NeoVac was created with the goal of developing the next generation of mRNA vaccines, using ground-breaking new IP for Lipid Nanoparticles developed at Tel-Aviv university. Our researchers at the Harwell Campus are working to expand the scope of the possible for the mRNA vaccine.